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Toll-like receptor 7 (TLR7) and TLR9 sense viral
nucleic acids and induce production of type I inter-
feron (IFN) by plasmacytoid dendritic cells (pDCs)
to protect the host from virus infection. We showed
that the IFN-inducible antiviral protein Viperin
promoted TLR7- and TLR9-mediated production of
type I IFN by pDCs. Viperin expression was potently
induced after TLR7 or TLR9 stimulation and Viperin
localized to the cytoplasmic lipid-enriched compart-
ments, lipid bodies, in pDCs. Viperin interacted with
the signal mediators IRAK1 and TRAF6 to recruit
them to the lipid bodies and facilitated K63-linked
ubiquitination of IRAK1 to induce the nuclear translo-
cation of transcription factor IRF7. Loss of Viperin
reduced TLR7- and TLR9-mediated production of
type I IFN by pDCs. However, Viperin was dispens-
able for the production of type I IFN induced by intra-
cellular nucleic acids. Thus, Viperin mediates its
antiviral function via the regulation of the TLR7 and
TLR9-IRAK1 signaling axis in pDCs.
INTRODUCTION
Innate immunity, the first line of host defense against infectious
agents, is initiated after the recognition of components of patho-
gens by pattern-recognition receptors (PRRs) (Medzhitov, 2009;
O’Neill and Bowie, 2010; Takeuchi and Akira, 2010). PRRs, such
as the Toll-like receptor (TLR), RIG-I-like receptor (RLR),
NOD-like receptor (NLR), and the C-type lectin family, drive the
coordinated activation of signaling pathways to produce type I
interferon (IFN), proinflammatory cytokines, and chemokines,
resulting in the induction of host defense response (Medzhitov,
2009; O’Neill and Bowie, 2010; Takeuchi and Akira, 2010).
Production of type I IFN is induced after the detection of viral
nucleic acids by PRRs and plays a central role in the establish-
ment of an antiviral state (Medzhitov, 2009; O’Neill and Bowie,
2010; Takeuchi and Akira, 2010). RNA helicases RIG-I and
MDA-5, known as RLRs, sense RNA of RNA viruses in the352 Immunity 34, 352–363, March 25, 2011 ª2011 Elsevier Inc.cytoplasm and activate transcription factors IRF3 and IRF7,
which induce interferon stimulation responsive element-depen-
dent transcription, resulting in the production of type I IFN
(Yoneyama and Fujita, 2010). In contrast, stimulator of interferon
genes (STING; also known asMPYS, MITA, or ERIS) mediate the
activation of the IRF3-dependent innate immune response
induced by a cyclic diadenosine monophosphate of Listeria
monocytogenes and a double stranded (ds) DNA of DNA viruses
(Ishikawa et al., 2009). The IRF3- and IRF7-dependent innate
immune responses are also induced after TLR stimulation
(Medzhitov, 2009; O’Neill and Bowie, 2010; Takeuchi and Akira,
2010). TLR3 and TLR4 induce IRF3- and IRF7-dependent
production of type I IFN after the recognition of extracellular
dsRNA and lipopolysaccharide (LPS), respectively (Kawai and
Akira, 2010). Plasmacytoid dendritic cells (pDCs) produce aburst
amount of type I IFN after the engagement of TLR7 and TLR9.
TLR7 detects the single stranded (ss) RNA of RNA viruses and
TLR9 detects unmethylated CpG DNA of DNA viruses (Blasius
and Beutler, 2010). In pDCs, the engagement of TLR7 or TLR9
in lysosomes triggers the potent activation of IRF7 via kinases
IRAK1 and IKKa, leading to the robust production of type I IFN
(Blasius and Beutler, 2010).
Inflammatory cytokines and chemokines are also required for
the host defense response (Medzhitov, 2009; O’Neill and
Bowie, 2010; Takeuchi and Akira, 2010). The engagement of
all TLR members and NOD1 and NOD2 triggers the production
of proinflammatory cytokines and chemokines via the activa-
tion of the transcription factor NF-kB (Medzhitov, 2009; O’Neill
and Bowie, 2010; Takeuchi and Akira, 2010). C-type lectins,
such as Dectin-1, also mediate the production of inflammatory
cytokines via the tyrosine kinase Syk-dependent pathway
(Takeuchi and Akira, 2010). Inflammasomes, the caspase-1
containing complexes, induce the processing of pro-IL-1b
and subsequent production of the inflammatory cytokine
IL-1b after microbial infection (Schroder and Tschopp, 2010).
The three types of recognized inflammasomes are: the AIM2
(absent in melanoma 2) inflammasome, activated by cytosolic
microbial dsDNA; IPAF (Ice protease-activating factor), acti-
vated by bacterial flagellin; and NALP3 (NACHT, LRR, and
PYD domains-containing protein 3), activated after damage in
an organelle such as disrupted homeostasis of the Golgi appa-
ratus by the M2 protein of influenza virus (Schroder and
Tschopp, 2010; Ichinohe et al., 2010).
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Role for Viperin in Type I IFN ProductionThe IFN-inducible genes, which are upregulated after stimula-
tion by IFNs and the engagement of PRRs, are critically involved
in the host defense response against infectious agents (Honda
et al., 2006). Targeted disruption of IRF3 and IRF7 and type I
IFN receptors renders the host susceptible to viral infection,
clearly indicating the importance of type I IFN in antiviral innate
immunity (Honda et al., 2006). Although the mechanism under-
lying the direct elimination of viruses by IFN-inducible genes
has been studied for some time, there are still IFN-inducible
genes of unknown function in PRR-triggered signaling pathways.
Therefore, clarification of the roles of IFN-inducible genes in the
regulation of PRR-mediated innate immune responses is clearly
important in order to understand host defense.
In the present study we focused on Viperin (also known as
RSAD2, Vig1, or Cig5), which was originally identified as one of
the inducible genes during infection with human cytomegalo-
virus (Chin and Cresswell, 2001). Viperin is also induced by
type I IFN, type II IFN, LPS, and RNA viruses (Chin and Cresswell,
2001; Severa et al., 2006). Viperin localizes on the endoplasmic
reticulum and Golgi apparatus and is transported to lipid-en-
riched compartments called lipid droplets (Chin and Cresswell,
2001; Hinson and Cresswell, 2009a; Hinson and Cresswell,
2009b). Viperin harbors an amphipathic a-helix domain at its
N-terminus and functions by anchoring on a lipid layer via this
domain (Hinson and Cresswell, 2009b). Viperin suppresses the
replication of influenza virus by disrupting the lipid rafts (Wang
et al., 2007). Viperin can also suppress the replication of other
types of viruses probably by acting as a radical S-adenosylme-
thionine (SAM) enzyme (Jiang et al., 2008; Jiang et al., 2010;
Duschene andBroderick, 2010; Shaveta et al., 2010). Recentstu-
dies have revealed that Viperin is involved in the activation of
NF-kB and AP-1 in T cells (Qiu et al., 2009). However, it is
unknownwhether Viperin is involved in the PRR-mediated innate
immune response. Here, we examined the potential involvement
of Viperin in PRR-induced production of type I IFN, inflammatory
cytokines, and chemokines and showed Viperin is important in
TLR7- and TLR9-mediated production of type I IFN by pDCs.
RESULTS
Viperin Expression Induced by Pathogens
We examined the expression of Viperin after the engagement of
various types of PRRs. The engagement of TLR3 and that of
TLR4 resulted in the induction of Viperin in peritoneal macro-
phages (Figure 1A). The engagement of TLR7 and that of TLR9
also resulted in the induction of Viperin in splenic pDCs (Fig-
ure 1B). However, ligands for TLR2 or TLR5 failed to trigger the
induction of Viperin (Figure 1A). Curdlan and zymosan, ligands
for C-type lectin Dectin-1, also failed to induce the expression
of Viperin (Figure 1A). The activation of RLR- or STING-signaling
pathway resulted in the induction of Viperin in GMCSF-induced
DCs (Figures 1C and 1D). The expression of Viperin was also
induced after infection by Salmonella typhimurium, which
triggered both TLR- and NLR-dependent signals (Figure 1D).
We examined whether the induction of Viperin was regulated
by IRF3 and a related transcription factor IRF7 because IRF3 is
able to induce the transcription of Viperin, and these transcrip-
tion factors are activated by nucleic acids and LPS (Severa
et al., 2006; Ishikawa et al., 2009; Kawai and Akira 2010;Yoneyama and Fujita, 2010). Upregulation of Viperin by the path-
ogens was disrupted in macrophages or GMCSF-induced DCs
lacking both IRF3 and IRF7. (Figures 1A, 1C, and 1D). In pDCs,
IRF7 is required for TLR7 and TLR9-mediated expression of
Viperin (Figure 1B). These results indicated that various types
of PRRs could trigger the induction of Viperin via the activation
of IRF3 and IRF7 and suggested a potential involvement of
Viperin in the regulation of the PRR-mediated innate immune
response.Viperin Facilitates TLR7/9-Dependent Production
of Type I IFN
To investigate a role for Viperin in the PRR-mediated innate
immune response, we generated Viperin-deficient (Rsad2/)
mice (Figure S1A available online). Successful targeted disrup-
tion of the Viperin gene locuswas confirmed by Southern blotting
analysis (Figure S1B). Neither Viperin mRNA nor Viperin protein
was detected in Rsad2/ embryonic fibroblasts (Figures S1C
and S1D). Rsad2/ mice were found at Mendelian ratios and
grew normally (Figure S1E).
We then assessed whether Viperin regulates TLR-dependent
production of type I IFN. The production of type I IFN after the
engagement of TLR7 with heat-treated Newcastle disease virus
(NDV) or TLR9 by CpG DNA was impaired in Rsad2/ FLT3L-
induced DCs (Figures 2A and 2B). CpG DNA-induced IFN-b
mRNA synthesis was attenuated in Rsad2/ FLT3L-induced
DCs, indicating that IFN-b production is reduced at the transcrip-
tional level (Figure 2C). Viperin deficiency reduced the amount of
intracellular IFN-a protein in B220+ FLT3L-induced DCs (Fig-
ure 2D). Consistent with these results, the production of IFN-a
induced by A- and D-type CpG DNA was impaired in Rsad2/
splenic pDCs, and the amount of IFN-a in the serum was
reduced in Rsad2/ mice injected with A- or D-type CpG DNA
(Figures 2E and 2F). These results indicated that Viperin
promotes TLR7 and TLR9-dependent production of type I IFN
by pDCs. However, Viperin was not involved in the production
of IL-12 p40 after TLR7 or TLR9 stimulation, suggesting a selec-
tive requirement of Viperin in the TLR7 and TLR9-mediated
signaling pathway (Figures 2A–2C, 2E, and 2F). Complementa-
tion of wild-type Viperin, but not the N-terminal deletion mutant,
into Rsad2/ FLT3L-DCs restored IFN-b production induced by
TLR7 or TLR9 engagement (Figure 2G). Because the N terminus
of the Viperin protein is an amphipathic a-helix responsible for
membrane association, anchoring on the membrane compart-
ments is required for its function in the TLR7- or TLR9-mediated
innate immune response. Viperin was dispensable for the TLR4-
mediated IFN response because Rsad2/ GMCSF-induced
DCs produced normal amounts of IFN-b and CXCL10, an
IFN-inducible chemokine, in response to LPS (Figure 2H).
We also assessed the involvement of Viperin in the production
of type I IFN induced by intracellular nucleic acids. The produc-
tion of type I IFN induced by transfected dsRNA or dsDNA was
also normal in Rsad2/ MEFs (Figure S2A). Viperin was
dispensable for the production of type I IFN induced by NDV,
encephalomyocarditis virus (EMCV), L. monocytogenes, or
herpes simplex virus 1 (HSV1) (Figures S2B and S2C). These
results indicated that Viperin does not regulate RLR- and
STING-mediated IFN-b production.Immunity 34, 352–363, March 25, 2011 ª2011 Elsevier Inc. 353
Figure 1. Induction of Viperin after Sensing of Pathogens
(A) Peritoneal macrophages from Irf3+/Irf7+/ and Irf3/Irf7/ mice were stimulated with the indicated ligands for 5 hr. Whole-cell lysate was subjected to
immunoblotting analysis with the indicated antibodies.
(B) Splenic plasmacytoid dendritic cells from Irf3+/Irf7+/ and Irf3+/Irf7/ mice were stimulated with indicated ligands for 5 hr.
(C) GMCSF-induced bone marrow dendritic cells from Irf3+/Irf7+/ and Irf3/Irf7/mice were infected with live Newcastle disease virus (NDV) at a multiplicity
of infection (MOI) equal to one or heat-treated (H.T.) NDV for 24 hr or were stimulated with dsRNA (poly rI-rC) plus LF2000 or IFN-b for 8 hr.
(D) Peritoneal macrophages from Irf3+/Irf7+/ and Irf3/Irf7/ mice were infected with S. typhimurium (MOI = 0.1) or L. monocytogenes (MOI = 20) for 24 hr
or were stimulated with dsDNA (poly dA-dT) plus LF2000 for 8 hr. Data are representative of two independent experiments.
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Role for Viperin in Type I IFN ProductionWe next examined the involvement of Viperin in PRR-induced
production of inflammatory cytokines. Rsad2/ macrophages
produced a normal amount of TNF and IL-6 after the engage-
ment of TLR2, TLR4, TLR7, or TLR9 (Figure S2D). Viperin was
also dispensable for the production of TNF and IL-1b after the
engagement of Dectin-1 (Figure S2E). Viperin deficiency did
not affect the production of IL-1b by the activation of the
AIM2-, IPAF-, or NALP3 inflammasome (Figures S2F and S2G).
Viperin was not involved in the enhancement of IL-6 production
induced by the engagement of NOD1 or NOD2 (Figure S2H).354 Immunity 34, 352–363, March 25, 2011 ª2011 Elsevier Inc.These results indicated that Viperin does not regulate the
production of inflammatory cytokines.
Interaction of Viperin with IRAK1 and TRAF6
Specific involvement of Viperin in TLR7 or TLR9-dependent type
I IFN production prompted us to examine the molecular function
of Viperin. The population of Rsad2/ B220+CD11C+ cells
(generally regarded as pDCs; Blasius and Beutler, 2010; Kawai
and Akira, 2010) was normal in splenocytes and in FLT3L-
induced bone-marrow-derived cells, indicating that Viperin is
Figure 2. Viperin Promotes TLR7 and TLR9-
Dependent Production of Type I IFNs by
Plasmacytoid Dendritic Cells
(A and B) Rsad2+/+ or Rsad2/ FLT3L-induced
bone marrow dendritic cells were stimulated with
TLR7 ligands (H.T. NDV and R848) or TLR9 ligands
(D19, D35 and ODN1668). Culture supernatant
was collected 24 hr after stimulation and sub-
jected to ELISA. The results shown are mean ± SD
(n = 3). Statistical significance (p value) was
determined by the Student’s t test. *p < 0.01 (C)
Rsad2+/+ or Rsad2/ FLT3L-induced bone-
marrow dendritic cells were stimulated with D19
(1 mM) for 8 hr. Total RNA was isolated and sub-
jected to quantitative RT-PCR analysis for IFN-b
and IL-12 p40.
(D) Intracellular IFN-a staining of Flt3L-induced
B220+ dendritic cells derived from Rsad2+/+ or
Rsad2/ mice. The D19-stimulated cells were
stained with anti-B220 and anti-IFN-a and were
subjected to flow cytometry analysis.
(E) Rsad2+/+ or Rsad2/ splenic plasmacytoid
dendritic cells were stimulated with D19 for 24 hr.
(F) Rsad+/+ or Rsad2/ mice were intravenously
injected with D19 for the indicated time periods.
The collected serum was subjected to ELISA.
(G) Viperinwild-type, ViperinD42, or ViperinC83/87/90A
protein was expressed in bone marrow cells iso-
lated from Rsad2/ mice. The transduced cells
were cultured in the presence of FLT3L for 7 days
and then stimulated with D19 (1 mM) for 24 hr.
Culture supernatant and whole-cell lysate were
subjected to ELISA and immunoblotting analysis
respectively.
(H) Rsad2+/+ or Rsad2/ GMCSF-induced bone
marrow dendritic cells were stimulated with LPS
(100 ng/mL) for 24 hr, and the culture supernatant
was subjected to ELISA. Data are representative
of three independent experiments.
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Role for Viperin in Type I IFN Productionnot necessary for the development of pDCs (Figures S3A and
S3B). Viperin does not regulate uptake of A- or D-type CpG
DNA because the population positive for the FITC-labeled CpG
DNA in Rsad2/ B220+CD11C+ DCs was comparable to that
in wild-type DCs (Figure S3C). The expression level of LC3-I
and LCII protein and p62 protein was not altered by Viperin
deficiency (Figure S3D), indicating that Viperin does not regulate
basal autophagy, which is required for the recognition of the viral
genome by TLR7 and TLR9 in pDCs (Lee et al., 2007).
BecauseViperinanchorson thecytoplasmic faceof a lipid layer
of the membrane compartments, we examined whether Viperin
regulates essential signal mediators, such as IKKa, IRAK1,
IRAK4, IRF7, MyD88, TRAF3, and TRAF6 (Kawai et al., 2004;Immunity 34, 352–36Honda et al., 2004; Uematsu et al., 2005;
Hoshino et al., 2006; Ha¨cker et al., 2006).
Viperin is dispensable for A- and D-type
CpG DNA-induced phosphorylation of
Ser176 and Ser180 residues of IKKa,
which is anessential step for IFN response
by pDCs (Figure S3E) (Gotoh et al., 2010).
In conventional dendritic cells (cDCs), B-
and K-type CpG DNA, but not A- andD-type CpG DNA, induces activation of the IKKa-IRF1 signaling
axis leading to IFN-b production (Hoshino et al., 2010). Viperin
was also dispensable for IKKa-mediated production of IFN-b
induced by B- and K-type CpG DNA in cDCs (Figure S3F). These
results indicated that Viperin does not regulate the activation of
IKKa. We assessed the interaction of Viperin with the remaining
essential mediators. When transiently expressed in 293 cells,
IRAK1 and TRAF6 interacted with Viperin, whereas the other
mediators, IRAK4, IRF7, MyD88, and TRAF3, appeared not to
interact with Viperin (Figures 3A and 3B). In FLT3-induced DCs
stimulated with A- andD-type CpG DNA, endogenous Viperin
interacted with endogenous IRAK1 and endogenous TRAF6
(Figures 3C and 3D). When ectopically expressed, ViperinD423, March 25, 2011 ª2011 Elsevier Inc. 355
Figure 3. Viperin Interacts with IRAK1 and TRAF6
(A and B) 293 cells were transfected with the indicated expression plasmids. Whole-cell lysate was subjected to immunoprecipitation coupled with immuno-
blotting analysis.
(C and D) FLT3L-induced bone marrow dendritic cells isolated from C57/BL6 mice were stimulated with D19 (1 mM) for 5 hr. Whole-cell lysate was subjected to
immunoprecipitation coupled with immunoblotting analysis.
(E and F) 293 cells were transfected with the indicated expression plasmids. Whole-cell lysate was subjected to immunoprecipitation coupled with immuno-
blotting analysis. IP, immunoprecipitation; IB, immunoblotting. Data are representative of two independent experiments.
Immunity
Role for Viperin in Type I IFN Productionwas coimmunoprecipitated with IRAK1 and TRAF6, indicating
that the N-terminal amphipathic a-helix of Viperin is not neces-
sarily required for its interaction with IRAK1 and TRAF6 (Figures
3E and 3F). These results suggested that Viperin regulates an
activation of IRAK1 and TRAF6 to promote TLR7- and TLR9-
mediated IFN production in pDC.356 Immunity 34, 352–363, March 25, 2011 ª2011 Elsevier Inc.Viperin Facilitates the K63-Linked Ubiquitination
of IRAK1 to Promote the Production of Type I IFN
TRAF6 is an E3 ubiquitin ligase and mediates the signals from
Toll and IL-1 receptors by inducing K63-linked ubiquitination of
various regulators including IRAK1 (Liu et al., 2005; Conze
et al., 2008; Bhoj and Chen, 2009). Because Viperin interacted
Figure 4. Viperin Facilitates K63-Linked
Ubiquitination of IRAK1 in Plasmacytoid
Dendritic Cells
(A) Rsad2+/+ or Rsad2/ FLT3L-induced bone-
marrow dendritic cells were stimulated with D19
(1 mM) for 5 hr. Whole-cell lysate was subjected to
immunoprecipitation coupled with immunoblot-
ting analysis.
(B) IRAK1wild-type or IRAK1K134R and K180R protein
was expressed in bone marrow cells isolated from
C57/BL6mice. The transduced cells were cultured
in the presence of FLT3L for 7 days and were
stimulated with D19 (1 mM) for 5 hr. Whole-cell
lysate was subjected to immunoprecipitation
coupled with immunoblotting analysis. IP, immu-
noprecipitation; IB, immunoblotting.
(C) IRAK1wild-type or IRAK1K134R and K180R protein
was expressed in bone marrow cells isolated from
Irak1-/Y mice. The transduced cells were cultured
in the presence of FLT3L for 7 days and were then
stimulated with D19 (1 mM) for 24 hr. Culture
supernatant and whole-cell lysate were subjected
to ELISA and immunoblotting analysis respec-
tively. EV, Empty vector. The results shown are
mean ± SD. Statistical significance (p value) was
determined by the Student’s t test. *p < 0.01.
Data are representative of three independent
experiments.
Immunity
Role for Viperin in Type I IFN Productionwith IRAK1 and TRAF6, we assessed the status of K63-linked
ubiquitination on IRAK1 in the presence or absence of Viperin.
K63-linked ubiquitination of IRAK1, which was induced by A-
and D-type CpG DNA, was attenuated in Rsad2/ FLT3L-DCs
(Figure 4A). Complementation of wild-type IRAK1, but not the
Lys134Arg and Lys180Arg IRAK1 mutant, which is defective in
K63-linked ubiquitination by TRAF6 (Figure 4B) (Conze et al.,
2008), into Irak1-/Y FLT3L-DCs restored the production of
IFN-b induced by the engagement of TLR9 (Figure 4C). The
K63-linked ubiquitination of IRAK1 induced by the ectopic
expression of TRAF6 is not regulated by Viperin, suggestingImmunity 34, 352–36that Viperin doesn’t directly support ubiq-
uitination of IRAK1 by TRAF6. (Figure S4)
These results indicated that Viperin
promotes TLR7 and TLR9-dependent
production of IFN-b production by facili-
tating K63-linked ubiquitination of IRAK1.
Recruitment of IRAK1 and TRAF6
to Lipid Bodies by Viperin
We investigated the localization of Viperin
in pDCs, and found that Viperin localized
on the cytoplasmic punctuate structures
(Figure 5A). It has been reported that
Viperin anchors to the cytosolic face of
adipocyte differentiation-related protein
(ADRP)-positive lipid-enriched compart-
ments known as lipid droplets and that
DCs have ADRP-positive lipid-enriched
compartments, termed lipid bodies, to
promote the immune response (Hinson
and Cresswell, 2009a; Bougne`res et al.,2009). On the basis of these reports, we examined whether
Viperin localizes on the lipid bodies in DCs. Viperin localized on
the punctate structures positive for the ADRP protein (Figure 5A)
(Bougne`res et al., 2009). The chemical inhibitor U18666A, which
disrupts formation of lipid-enriched compartments by reducing
up-take of lipids, attenuated TLR7- and TLR9-dependent
production of type I IFN by FLT3-induced DCs, indicating the
importance of lipid bodies for the signal transduction (Figure 5B).
IRAK1 and TRAF6 also localized on the punctate structures in
pDC after TLR9 stimulation (Figures 6A and 6B). Both endoge-
nous and exogenously expressed Viperin colocalized with3, March 25, 2011 ª2011 Elsevier Inc. 357
Figure 5. Viperin Localizes on Lipid Bodies in Plasmacytoid Dendritic Cells
(A)Rsad2+/+ orRsad2/FLT3L-induced bonemarrow dendritic cells were stimulatedwith D19 (1 mM) for 5 hr. The cells were fixedwith 3%paraformaldehyde and
subjected to immunocytochemistry. The B220+ dendritic cells were examined under a fluorescent microscope. Yellow arrows indicate the co-localization. DIC,
differential interference contrast. The scale bar represents 5 mm. The percentage of B220+ dendritic cells with ADRP+Viperin+ dots was measured (n = 200 each).
(B) Rsad2+/+ or Rsad2/ FLT3L-induced bone-marrow dendritic cells were pretreated with U18666A for 16 hr and then stimulated with D19 (1 mM). Culture
supernatant collected 24 hr after stimulation was subjected to ELISA. The results shown are mean ± SD.
Immunity
Role for Viperin in Type I IFN ProductionIRAK1 and TRAF6 on the punctate structures positive for the
BODIPY dye, a marker of lipid bodies, in pDC after TLR9 stimu-
lation (Figures 6A and 6B and Figures S5A–S5D). Viperin
deficiency disrupted the localization of IRAK1 and TRAF6 on
the BODIPY-positive punctate structures (Figures 6A and 6B).
Although TLR9 localized on the Viperin-positive lipid bodies
with low frequency, MyD88 localized on Viperin-positive lipid
bodies with moderate frequency (Figures S5E and S5F), sug-358 Immunity 34, 352–363, March 25, 2011 ª2011 Elsevier Inc.gesting that MyD88 mediates the signals from TLR9 on the lyso-
somes to IRAK1 and TRAF6 on the lipid bodies. Viperin also
colocalized with IRF7 in response to CpG DNA and facilitated
the subsequent nuclear translocation of IRF7, which is mediated
by IRAK1 (Figure 7). Viperinmight form a large complex with IRF7
and IRAK1 because IRF7was coimmunoprecipitated with IRAK1
and Viperin when these factors were ectopically expressed in
293 cells (Figure S6). These results indicated that Viperin is
Figure 6. Viperin Recruits IRAK1 and TRAF6
to the Lipid Bodies
(A and B) Rsad2+/+ or Rsad2/ FLT3L-induced
bone-marrow dendritic cells were stimulated with
D19 (1 mM) for 5 hr. The cells were fixed with 3%
paraformaldehyde and subjected to immunocyto-
chemistry. The B220+ dendritic cells were exam-
ined under a fluorescent microscope. Yellow
arrows indicate the colocalization. DIC, differential
interference contrast. The scale bar represents
5 mm. The percentage of B220+ dendritic cells with
the indicated dots was measured (n = 400 each).
Immunity
Role for Viperin in Type I IFN Productionimportant for the recruitment of IRAK1 and TRAF6 to the lipid
bodies, which are the transfer points in the TLR7 and TLR9
signaling pathway leading to the activation of IRF7.
DISCUSSION
It has become clear that intracellular membrane-surrounded
compartments play pivotal roles in the signal transduction from
PRRs detecting viral nucleic acids (Saitoh and Akira, 2010).
The signals from RLR are mediated by an adaptor protein,Immunity 34, 352–36IPS-1 (also known as MAVS, VISA, or
CARDIF), which is expressed on mito-
chondria and peroxisomes (Seth et al.,
2005; Dixit et al., 2010). Furthermore the
dsDNA-induced innate immune response
requires the dynamic translocation of
STING, a multispanning membrane
protein, from ER to cytoplasmic
membrane-bound structures (Ishikawa
et al., 2009; Saitoh et al., 2009). In the
present study, we demonstrated that the
N-terminal amphipathic a-helix of Viperin
is required for its function, indicating that
Viperin anchors on the membrane lipid
layer of lipid bodies and mediates the
signal from TLR7 and TLR9. Viperin
recruits IRAK1 and TRAF6 to the lipid
bodies in a stimulation-dependent
manner and facilitates the subsequent
K63-linked ubiquitination of IRAK1 by
TRAF6, which results in the IRF7-medi-
ated induction of type I IFN. Thus, the lipid
bodies are the major transit points in the
TLR7 and TLR9 signaling pathway leading
to the production of type I IFN in pDCs.
Although IRAK1 is specifically involved
in TLR-IL-1R signaling pathway, TRAF6
is critical in the signal transduction from
various immune-related receptors, such
as T cell receptor (TCR), RANK, CD40,
and TLR-IL-1R. Because it has been
reported that Viperin mediates TCR-
induced activation of NF-kB and AP-1, it
would be of interest to assess whether
Viperin promotes Bcl10-dependent K63-linked ubiquitination of NEMO by TRAF6, an essential process
of NF-kB activation induced by TCR (Liu et al., 2005; Qiu et al.,
2009; Bhoj and Chen, 2009).
A mechanism underlying the translocation of Viperin from the
ER to lipid bodies is still not known, whereas Unc93B1-depen-
dent translocation of TLR7 and TLR9 from the ER to endolyso-
somes has been revealed (Latz et al., 2004; Kim et al., 2008).
In this context, it would be of interest to assess the involvement
of autophagy-related proteins, regulators of membrane traf-
ficking (Saitoh and Akira, 2010), for the localization of Viperin3, March 25, 2011 ª2011 Elsevier Inc. 359
Figure 7. Viperin Colocalizes with IRF7 and Promotes the Nuclear Translocation of IRF7 after TLR9 Stimulation
Flag-tagged IRF7 protein was expressed in bone-marrow cells isolated from Rsad2+/+ or Rsad2/ mice. The transduced cells were cultured in the presence of
FLT3L for 7 days and stimulated with D19 (1 mM) for 5 hr. The cells were fixedwith 3%paraformaldehyde andwere subjected to immunocytochemistry. The B220+
dendritic cells were examined under a fluorescent microscope. Yellow arrows indicate the colocalization. DIC, differential interference contrast. The scale bar
represents 5 mm. The percentage of B220+ dendritic cells with IRF7+Viperin+ dots or with nuclear IRF7 was measured (n = 200 each).
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Role for Viperin in Type I IFN Productionon the lipid bodies. This is because Atg5, an autophagy-related
protein, is involved in the production of type I IFN by A- and
D-type CpGDNA aswell as in the recognition of the viral genome
by TLR7 and TLR9 (Lee et al., 2007). Atg7, another autophagy-
related protein, regulates the number and the size of lipid-en-
riched compartments in various types of cells (Czaja, 2010).
Furthermore, autophagy-related proteins are involved in the
translocation of membrane associated IFN-g-inducible p47
GTPase IIGP1 from the ER or Golgi apparatus to the lamp1-posi-
tive compartments after infection by Toxoplasma gondii360 Immunity 34, 352–363, March 25, 2011 ª2011 Elsevier Inc.(Zhao et al., 2008). Further studies will be required to address
this issue.
Viperin has been considered a radical SAM enzyme, given that
it harbors a CX3CX2C motif as well as some additional motifs
conserved in the radical SAM enzyme family (Duschene and
Broderick, 2010; Shaveta et al., 2010). It has been shown that
SAM is the methyl donor in the biological reaction and the
precursor of polyamines, which are often involved in the regula-
tion of cellular responses (Duschene and Broderick, 2010;
Shaveta et al., 2010). Radical SAM enzymes induce cleavage
Immunity
Role for Viperin in Type I IFN Productionof SAM to generate the 50-deoxyadenosyl radical, which contrib-
utes to the cleavage of C-H bonds in the alkyl group and alters
the local concentration of SAM (Duschene and Broderick,
2010; Shaveta et al., 2010). Recent studies have uncovered
that purified Viperin protein could contain a [4Fe-4S]+ cluster
under anaerobic conditions and induce the cleavage of SAM
in vitro, suggesting that Viperin acts as a radical SAM enzyme
during the antiviral response (Duschene and Broderick, 2010;
Shaveta et al., 2010). Indeed, mutations in the CX3CX2C motif
of the Viperin protein disrupt its ability to suppress the replication
of certain types of RNA viruses (Jiang et al., 2008; Jiang et al.,
2010). However, the exact mechanism through which the radical
SAM enzyme alters the function of Viperin on viral replication
remains unknown. We have observed partial involvement of
the CX3CX2C motif in the Viperin protein with regulation of the
TLR7 and TLR9-mediated production of type I IFN; it is difficult
to clarify the exact function of the Viperin CX3CX2C motif. In
future studies, identification of the chemical reaction catalyzed
by the radical SAM enzyme domain of Viperin would be impor-
tant in revealing the molecular function of Viperin during the
antiviral response.
Type I IFN triggersorchestratedexpressionof antiviral proteins.
Each IFN-inducible protein contributes to the antiviral response
at various stages and protects the host suffering from viral
infection. We here provide evidence that Viperin, the IFN-induc-
ible protein, acts as a regulator for PRR-mediated innate immune
response. Thus, Viperin plays dual roles: a direct suppression of
viral replication as reported and a facilitation of TLR7- and
TLR9-mediated production of type I IFN. Our study provides
insight into the role of Viperin in the regulation of host defense
responses to viruses. Although various IFN-inducible proteins,
such as the APOBEC family and Zinc finger antiviral proteins,
contribute to the direct suppression of viral replication, it remains
unclear whether such molecules are involved in the regulation of
PRR-triggered signaling pathways (Wolf and Goff, 2008; Neil and
Bieniasz, 2009). Therefore revalidation of the roles of IFN-induc-
ible proteins in PRR-mediated innate immune responses will be
needed for better understanding of host defense.
EXPERIMENTAL PROCEDURES
Mice and Cells
The methods for the generation of Viperin-deficient mice are described in the
Supplemental Experimental Procedures. Irak1-/Y mice were kindly donated by
J.A. Thomas (University of Texas Southwestern Medical Center, Texas, USA).
Irf3/ and Irf7/ mice were kindly donated by T. Taniguchi (University of
Tokyo, Tokyo, Japan). Mouse splenic plasmacytoid dendritic cells were
isolated with a Plasmacytoid Dendritic Cell Isolation Kit II (Miltenyi Biotec).
Mouse bone marrow dendritic cells and mouse thioglycollate-elicited perito-
neal macrophages were prepared as previously described (Kato et al., 2006;
Saitoh et al., 2008).
Mice were maintained in our animal facility and treated in accordance with
the guidelines of Osaka University.
Viruses and Bacteria
NDV has been described previously (Kato et al., 2006). Salmonella typhimu-
rium (SR-11 3 3181) was provided by the Kitasato Institute for Life Science.
Listeria monocytogenes was described previously (Uematsu et al., 2007).
Reagents
ADRP antibody was purchased from Abcam. Anti-IRAK1 and anti-Myc anti-
bodies were purchased from Cell Signaling Technology. Actin and TRAF6antibodies were purchased from Santa Cruz Biotechnology. Viperin antibody
was purchased from Hycult biotech. Ubiquitin (Lys63-specific clone Apu3)
antibody was purchased from Millipore. Flag antibody and Poly (dA-dT)
were purchased from Sigma. Poly (rI-rC) was purchased from GE Healthcare.
Depleted zymosan, FITC-labeled ODN1585, Flagellin, LPS, and Pam3CSK4
were purchased from Invivogen. R848 was purchased from Alexis. Curdlan
was purchased fromWAKO. Lipofectamine 2000, BODIPY, and alexa-labeled
secondary antibodies were purchased from Invitrogen. ELISA kits for mouse
CXCL10 and IL-12 p40 were purchased from R&D Systems. ELISA kits for
mouse IFN-a and IFN-b, and recombinant mouse IFN-b were purchased
from PBL InterferonSource. Recombinant mouse GMCSF and human FLT3L
were purchased from Peprotech. D19, D35, and ODN1668 were synthesized
as described previously (Kawagoe et al., 2007).
Plasmids
pcDNA3.1 (+) was purchased from Invitrogen. The retroviral expression
construct pMX was kindly donated by T. Kitamura (The University of Tokyo,
Tokyo, Japan). pMRX, a derivative of pMX, was kindly donated by S. Yamaoka
(Tokyo Medical and Dental University, Tokyo, Japan). pMRX-ires-puro and
pMRX-ires-bsr have been described previously (Saitoh et al., 2003). Comple-
mentary DNA encoding the Myc-tag sequence and mouse Viperin was
inserted into pcDNA3.1 (+) and pMRX-ires-puro, generating pcDNA3-Myc-Vi-
perin and pMRX-Myc-Viperin-ires-puro, respectively. Complementary DNA
encoding the Flag-tag sequence and mouse IRF7 was inserted into
pMRX-ires-puro, generating pMRX-IRF7-Flag-ires-puro. Complementary
DNA encoding IRAK1wild-type or IRAK1K134R and K180R was amplified by
PCR with pcDNA3-V5-IRAK1Wild-type or pcDNA3-V5-IRAK1K134R and K180R
(kind gifts from J.D. Ashwell; National Cancer Institute, Maryland, USA) as
a template. The inserts were cloned into pMRX-ires-puro, generating pMRX-
IRAK1WT-ires-puro and pMRX-IRAK1K134R and K180R-ires-puro, respectively.
The expression plasmids for Flag-tagged MyD88, IRAK4, IRAK1, TRAF6,
and IRF7 have been described previously (Kawai et al., 2004; Uematsu
et al., 2005). The pCMV-3xFlag hTRAF3 plasmid was provided by T. Yasui
(Osaka University, Osaka, Japan).
Retroviral Gene Transduction
The Plat-E cells used for the generation of recombinant retrovirus were kindly
donated by T. Kitamura (The University of Tokyo, Tokyo, Japan). Retroviral
infection was performed as previously described (Saitoh et al., 2008).
RT-PCR
Total RNA was isolated with RNAeasy Mini kits (QIAGEN) in accordance with
the manufacturer’s instructions. Reverse transcription was performed with
ReverTra Ace (TOYOBO) in accordance with the manufacturer’s instructions.
For quantitative PCR, cDNA fragments were amplified by Real-Time PCR
Master Mix (TOYOBO) in accordance with the manufacturer’s instructions.
Fluorescence from the TaqMan probe for each cytokine was detected by
a 7500 Real-Time PCR System (Applied Biosystems). For determining the
relative induction of IFN-b and IL12 p40 mRNA, the mRNA expression level
of each gene was normalized to the expression level of 18S RNA.
Immunoblotting and Immunoprecipitation
Immunoblotting and immunoprecipitation were performed as previously
described (Saitoh et al., 2006).
ELISA
The level of cytokine production was measured by ELISA in accordance with
the manufacturer’s instructions.
Immunocytochemistry
Immunofluorescence staining was performed as previously described (Saitoh
et al., 2008). In brief, the paraformaldehyde fixed cells were permeabilized with
saponin and were incubated in PBS with 1% goat serum and 5% fetal calf
serum (FCS) for the blocking. The immunofluorescence staining was per-
formed in FCS-containing PBS with the indicated antibodies and then with
the appropriate fluorescent dye-labeled secondary antibodies. The cells
were subsequently stained with biotin-labeled anti-B220 antibody andImmunity 34, 352–363, March 25, 2011 ª2011 Elsevier Inc. 361
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Role for Viperin in Type I IFN ProductionStreptavidin-Qdot625. Samples were examined under an IX81-DSU spinning
disc confocal microscope (Olympus).
Intracellular IFN-a Staining
Flt3L-induced bone marrow DCs were stimulated with D19 (1 mM) for 5 hr and
were cultured in the presence of Golgi stop for an additional 3 hr. The cells
were fixed in paraformaldehyde and permeabilized by saponin-containing
buffer. The cells was stained by a mixture of rat anti-mouse IFN-a antibodies
(clone F18 purchased from Hycult Biotechnology and clone RMMA-1
purchased from PBL Biomedical Laboratories) and subsequently by biotiny-
lated mouse anti-rat IgG antibody (Jackson Immuno Research Laboratories)
and Streptavidin-APC. The cells were subsequently stained with PE-labeled
anti-B220 antibody and analyzed on a FACS Calibur (BD Biosciences).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.
immuni.2011.03.010.
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